78,656 Shares in Guardian Pharmacy Services, Inc. $GRDN Acquired by Bessemer Group Inc.

Bessemer Group Inc. purchased a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 78,656 shares of the company’s stock, valued at approximately $2,962,000.

A number of other institutional investors also recently bought and sold shares of the business. Valiant Capital Management L.P. lifted its stake in Guardian Pharmacy Services by 15.8% during the 4th quarter. Valiant Capital Management L.P. now owns 1,232,463 shares of the company’s stock valued at $37,085,000 after acquiring an additional 167,741 shares during the period. Wellington Management Group LLP increased its stake in shares of Guardian Pharmacy Services by 3.3% in the third quarter. Wellington Management Group LLP now owns 1,143,729 shares of the company’s stock worth $30,000,000 after acquiring an additional 36,072 shares during the period. Franklin Resources Inc. raised its holdings in shares of Guardian Pharmacy Services by 8.2% during the third quarter. Franklin Resources Inc. now owns 1,056,240 shares of the company’s stock worth $27,705,000 after purchasing an additional 80,033 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Guardian Pharmacy Services by 9.1% during the third quarter. Vanguard Group Inc. now owns 1,055,102 shares of the company’s stock worth $27,675,000 after purchasing an additional 88,296 shares during the last quarter. Finally, Boston Partners lifted its position in Guardian Pharmacy Services by 0.7% during the fourth quarter. Boston Partners now owns 1,054,636 shares of the company’s stock valued at $31,995,000 after purchasing an additional 7,759 shares during the period.

Guardian Pharmacy Services Price Performance

NYSE:GRDN opened at $40.80 on Wednesday. The company has a 50 day moving average price of $40.14 and a 200-day moving average price of $36.19. Guardian Pharmacy Services, Inc. has a 1-year low of $19.30 and a 1-year high of $44.00. The firm has a market cap of $2.03 billion, a price-to-earnings ratio of 49.15, a price-to-earnings-growth ratio of 2.61 and a beta of 0.05.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.05. The firm had revenue of $336.60 million for the quarter, compared to the consensus estimate of $329.89 million. Guardian Pharmacy Services had a net margin of 3.64% and a return on equity of 30.72%. The firm’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.22 earnings per share. On average, sell-side analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current fiscal year.

Analyst Ratings Changes

GRDN has been the topic of several recent research reports. Jefferies Financial Group started coverage on shares of Guardian Pharmacy Services in a report on Monday, March 30th. They issued a “buy” rating and a $44.00 price target on the stock. Truist Financial lifted their price objective on Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Bank of America boosted their price objective on Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. Oppenheimer upped their target price on Guardian Pharmacy Services from $38.00 to $43.00 and gave the stock an “outperform” rating in a research note on Thursday, May 7th. Finally, Wall Street Zen lowered Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Seven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $42.83.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.